Zakarias Johanne Købstrup, Jensen-Dahm Christina, Nørgaard Ane, Stevnsborg Lea, Gasse Christiane, Andersen Bodil Gramkow, Søren Jakobsen, Waldorff Frans Boch, Moos Torben, Waldemar Gunhild
Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Laboratory of Neurobiology, Biomedicine Group, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
J Alzheimers Dis. 2016 Oct 4;54(3):1183-1192. doi: 10.3233/JAD-160485.
Use of antipsychotics in elderly patients with dementia has decreased in the past decade due to safety regulations; however use is still high. Geographical variation may indicate discrepancies in clinical practice and lack of adherence to evidence-based guidelines for the management of behavioral symptoms.
To investigate potential geographical variances in use of antipsychotic drugs in dementia care.
A registry-based cross-sectional study in the entire elderly population of Denmark (≥65 years) conducted in 2012. Data included place of residence, prescriptions filled, and hospital discharge diagnoses. Antipsychotic drug use among elderly with (n = 34,536) and without (n = 931,203) a dementia diagnosis was compared across the five regions and 98 municipalities in Denmark, adjusted for age and sex.
In 2012, the national prevalence of antipsychotic drug use was 20.7% for elderly patients with dementia, with a national incidence of 3.9%. The prevalence ranged from 17.0% to 23.3% in the five regions and from 7.5% to 33.1% in the 98 municipalities, demonstrating an over four-fold difference.
The observed geographical variation was more pronounced at municipal level as compared to regional level, suggesting that the variation may be related to variances in clinical practice in primary care. This study highlights an urgent need for further educating professional carers and physicians to guide non-pharmacological as well as pharmacological management of neuropsychiatric symptoms in elderly patients with dementia.
在过去十年中,由于安全规定,老年痴呆症患者使用抗精神病药物的情况有所减少;然而,使用率仍然很高。地理差异可能表明临床实践存在差异,并且在行为症状管理方面缺乏对循证指南的遵循。
调查痴呆症护理中抗精神病药物使用的潜在地理差异。
2012年在丹麦全体老年人口(≥65岁)中进行了一项基于登记处的横断面研究。数据包括居住地、所填处方以及医院出院诊断。在丹麦的五个地区和98个市,对有(n = 34,536)和没有(n = 931,203)痴呆症诊断的老年人的抗精神病药物使用情况进行了比较,并对年龄和性别进行了调整。
2012年,老年痴呆症患者使用抗精神病药物的全国患病率为20.7%,全国发病率为3.9%。五个地区的患病率在17.0%至23.3%之间,98个市的患病率在7.5%至33.1%之间,差异超过四倍。
与地区层面相比,观察到的地理差异在市一级更为明显,这表明这种差异可能与初级保健临床实践中的差异有关。本研究强调迫切需要进一步培训专业护理人员和医生,以指导老年痴呆症患者神经精神症状的非药物和药物管理。